cytarabine
NDC 25021-229 · Sagent Pharmaceuticals
Generic namecytarabine
Dosage formINJECTION, SOLUTION
RouteINTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Active ingredient(s)CYTARABINE
Strength20 mg/mL
Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
Marketing categoryANDA
Packages
25021-229-05 — 5 VIAL in 1 CARTON (25021-229-05) / 5 mL in 1 VIAL
Billed under HCPCS
J9100 — Injection, cytarabine, 100 mg Medicare Part B payment limit (ASP + 6%): $0.85
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
25021-223 — cytarabine, 61703-155 — CYTARABINE, 61703-303 — CYTARABINE, 61703-304 — CYTARABINE, 61703-305 — CYTARABINE, 61703-319 — CYTARABINE, 63323-120 — CYTARABINE, 68083-337 — Cytarabine, 68083-343 — Cytarabine, 68727-745 — (daunorubicin and cytarabine) liposome, 71288-108 — Cytarabine, 71288-109 — Cytarabine, 71288-168 — Cytarabine, 71288-169 — Cytarabine